Navigation Links
Inverness Medical Innovations Announces Second Quarter 2008 Results
Date:7/29/2008

hment

of related debt during the six months ended June 30, 2007, in conjunction

with our financing arrangements.

(g) A $1.7 million net realized foreign currency loss associated with a

cash escrow established in connection with the acquisition of BBI Holdings

Plc.

(h) A $1.9 million foreign currency gain realized on the settlement of

intercompany notes.

(i) Tax effect on adjustments as discussed above in notes (b), (c), (d),

(e), (f), (g) and (h).

(j) For the six months ended June 30, 2008 and 2007, potential dilutive

shares were not used in the calculation of diluted net loss per common

share under GAAP because inclusion thereof would be antidilutive.

(k) Included in the weighted average diluted common shares for the

calculation of net income per common share for the three months ended June

30, 2008, on an adjusted cash basis, are dilutive shares consisting of

2,344,000 common stock equivalent shares from the potential exercise of

stock options and warrants and potential dilutive shares consisting of

3,411,000 common stock equivalent shares from the potential conversion of

convertible debt securities. The net income per diluted share calculation

for the six months ended June 30, 2008, on an adjusted cash basis,

includes the add back of interest expense related to the convertible debt

of $1.5 million resulting in net income available to common stockholders

of $70.2 million. Potential dilutive shares consisting of 3,004,000 common

stock equivalent shares from the potential conversion of Series B

convertible preferred stock for the six months ended June 30, 2008 were

not used in the calculation of diluted net income per common share, on an

adjusted cash basis, because inclusion thereof would be antidilutive.

(l) Included in the weighted average diluted common shares for the

calculation of ne
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
2. Inverness - Chemogen Establish Exclusive License for TB Antibodies
3. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
4. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
7. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Germany, December 16 Eppendorf has ... and Verigene(R) SP systems for,infringement of European ... "Method for the,identification and/or the quantification of ... and all imports of the respective products ... authorities are required to confiscate any,violating products. ...
(Date:12/15/2009)... of three Department of Energy (DOE) bio-energy research centers, ... its valuable intellectual property. , ... ... -- Surety, LLC , the leading provider of ... the Joint BioEnergy Institute (JBEI), one of three Department ...
(Date:12/15/2009)... Medical, Inc. (OTC Bulletin Board : AEMD) announced ... Comper have joined the Science Advisory ... Schorey and Dr. Comper are leading researchers in ... of Aethlon Medical, was recently formed to leverage ... being advanced as an adjunct therapy for Hepatitis-C ...
(Date:12/15/2009)... The International Society for Medical Publication ... is continuing to accept abstracts for its 6th ... VA, April 19-21, 2010. This marks the first ... join the organization to submit an abstract to ... 12 AM EST, January 15, 2010. For submission ...
Breaking Biology Technology:Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3
... one bugbear above all: complexity. That was the view presented ... panelists and attendees of the Fusion2006 CEO-CIO Symposium. ... Frank Timons, an analysit with R.W. Baird & Co. He ... too many vendors, too many business processes, too many things ...
... together so well because they know they share the same ... CEO of Alliant Energy said Thursday that chief ... at the hip" if information technology is to support a ... Thursday at the Fusion 2006 CEO-CIO Symposium produced ...
... presenting at this year's InvestMidwest Venture Capital Forum , out ... a crowd of venture capitalists and trying to make the right ... Milwaukee just over a year ago based on technology developed in ... a rare debilitating disease. The company was drawn to Wisconsin in ...
Other Biology Technology:Simplicity appeals to CIOs, but it's no easy task 2Simplicity appeals to CIOs, but it's no easy task 3CEOs and CIOs must be 'joined at the hip' 2CEOs and CIOs must be 'joined at the hip' 3Lone Wisconsin firm to present at InvestMidwest 2
(Date:12/15/2009)... Dec. 15 The 2009 Frost ... Award is presented to Sagem Securite (Safran ... systems. The award recognises the company,s expertise ... stewardship in offering novel, value-added products to ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, "Sagem Securite has been ...
(Date:12/15/2009)... Fla. When treating devastating brain diseases such as ... bags to find something to help a patient. , ... help the vast majority of patients with ataxia ... coordination. , University of Florida neurologists are trying to ... Challenge grant from the National Institute of Neurological Disorders ...
(Date:12/15/2009)... 2009 Economics, environmental impacts, social dynamics, and ... the overall success of an agroecosystem. Positive or ... forcing individuals and social groups to continuously adapt ... , Experiential learning theory suggests that knowledge ... experiences. Such lessons are especially valuable for environmental ...
Breaking Biology News(10 mins):Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Experiential learning teaches change and adaptation 2Senetek PLC Reports Second Quarter 2009 Financial Results 54573 1Senetek PLC Reports Second Quarter 2009 Financial Results 54573 2Senetek PLC Reports Second Quarter 2009 Financial Results 54573 3Senetek PLC Reports Second Quarter 2009 Financial Results 54573 4Senetek PLC Reports Second Quarter 2009 Financial Results 54573 5Senetek PLC Reports Second Quarter 2009 Financial Results 54573 6Company Reverses Course 3A The Billboard Roy Blunt Doesnt Want You To See Will Go Up After All 54571 1Company Reverses Course 3A The Billboard Roy Blunt Doesnt Want You To See Will Go Up After All 54571 2AMDL Inc Files Notification of Late Filing for Form 10 Q 54569 1AMDL Inc Files Notification of Late Filing for Form 10 Q 54569 2
... person has managed to live much longer than a century. ... extended the average human life span, it is clear there ... lays the blame on the accumulation of damage done to ... the metabolic activity of mitochondria. , This damage is expected ...
... Doctors today presented more evidence that it's time for ... aside when it comes to the treatment of strep ... the strep germ, the bug that causes millions of ... doing the job and aren't as effective as newer ...
... in the nematode model organism C. elegans has provided much insight ... involved in aging in the worm have a similar role in ... McGill University (Canada) report that inactivation of the gene mclk1, the ... cellular fitness and prolonged lifespan in mice. , The ...
Other Biology News:Carnegie Mellon scientists create PNA molecule with potential to build nanodevices 2Penicillin, amoxicillin: Step aside for strep throat treatment 2Penicillin, amoxicillin: Step aside for strep throat treatment 3Evolutionary conservation of a mechanism of longevity from worms to mammals 2
... Diluted Antiserum for RIA, Host: Rabbit ... Immunology Products, Host: Rabbit Antigen ... peptide and 1 2 ... (rat) (H-9295) and ([ 1 2 ...
...
RatTRAPTM Assay is a solid-phase immunofixed enzyme activity assay for the determination of osteoclast-derived TRACP 5b activity in rat serum....
... EnzChek Pyrophosphate Detection Kit,provides a fast, ... the inorganic pyrophosphate (PPi ) produced,by ... as DNA and,RNA polymerizations, cyclic AMP ... the enzymatic activation of fatty acids ...
Biology Products: